Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Hair growth promoter described by BMS for use in male pattern baldness

Feb. 9, 2000

Methods of wound healing using amphipathic peptides from Demegen

Feb. 8, 2000

New Sumitomo compounds inhibit cytokine and IgE production

Feb. 8, 2000

Cellegy to commence phase II trial of Anogesic as hemorrhoid treatment

Feb. 8, 2000

Alexion to commence development of 5G1.1 for treatment of dermatomyositis

Feb. 3, 2000

IGI and Fujisawa collaborate on topical formulations of dermatological product

Jan. 27, 2000

Micrologix Biotech commences phase I trial for acne therapy

Jan. 25, 2000

Access cleared to commence phase III OraDisc study in the U.K.

Jan. 25, 2000

Cellegy expands Anogesic clinical trial for reduction of pain in hemorrhoidectomy

Jan. 24, 2000

Preparation, use and pharmaceutical compositions of new Galderma compounds

Jan. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...